Obefazimod in patients with moderate-to-severely active ulcerative colitis: efficacy and safety analysis from the 96-week open-label maintenance phase 2b study
奥贝法齐莫德治疗中重度活动性溃疡性结肠炎患者的疗效和安全性分析:一项为期 96 周的开放标签维持期 2b 研究
期刊:Journal of Crohns & Colitis
影响因子:8.7
doi:10.1093/ecco-jcc/jjaf074
Vermeire, Severine; Nitcheu, Josianne; Gineste, Paul; Flatres, Aurélien; Santo, Julien; Scherrer, Didier; Peyrin-Biroulet, Laurent; Dulai, Parambir S; Danese, Silvio; Dubinsky, Marla; Tilg, Herbert; Siegmund, Britta; Hisamatsu, Tadakazu; Shan, Kejia; Rabbat, Christopher J; Sands, Bruce E